Immunosign® for Clinical research Large scale quantification of selected immune biomarkers

Immunosign® for Clinical Research (CR)

Immunosign® for Clinical Research is a suite of gene expression assays applicable to most cancer types and stages for clinical investigations.
    

  • Robust gene expression assays
  • Selection of key immune genes
  • Proprietary algorithm for unsurpassed results

Easy customization to include your biomarker of interest.

All assays are amenable to clinical trial assays and companion diagnostics.

More on our Assay Development capabilities Discover
See publications and posters on Immunosign® CR Ressources
Want to learn more on Immunosign® CR ? Contact us

 

 

HalioDx newsletter subscription


Join our newsletter and be the first to get notified on new updates.


× Hide this popup.